Synthesis of 1,4-Benzodiazepine-2,5-diones
Using an Ionic Liquid as a Soluble Support

Hongwei Xie; Cuifen Lu; Guichun Yang; Zuxing Chen

doi:10.1055/s-0028-1083289

PAPER

Synthesis of 1,4-Benzodiazepine-2,5-diones Using an Ionic Liquid as a Soluble Support

Hongwei Xie, Cuifen Lu, Guichun Yang*, Zuxing Chen
Ministry-of-Education Key Laboratory for the Synthesis and Application of Organic Functional Molecules, School of Chemistry and Chemical Engineering, Hubei University, Wuhan, Hubei, 430062, P. R. of China
e-Mail: yangguichun@hubu.edu.cn;

Abstract

Alle Artikel dieser Rubrik

Abstract

The first report of the use of an ionic liquid as a soluble support for the synthesis of 1,4-benzodiazepine-2,5-diones is reported in this paper. This synthetic method is simple and efficient and the products are obtained in good yields. All of the products were characterized by IR, ^¹H NMR, and ^¹³C NMR.

Key words

ionic liquid - synthesis - 1,4-benzodiazepine-2,5-diones - soluble support

Volltext

Referenzen

References

For recent articles on the syntheses and bioactivities of 1,4-benzodiazepine-2,5-diones, see:

1a Kamal A. Reddy KL. Devaiah V. Synlett 2004, 2533

1b Kamal A. Ramana AV. Reddy KS. Tetrahedron Lett. 2004, 45: 818

1c Sabb AL. Vogel RL. Welmaker GS. Sabalski JE. Coupet J. Dunlop J. Rosenzweig-Lipson S. Harrison B. Bioorg. Med. Chem. Lett. 2004, 14: 2603

1d Li XY. Cao H. Zhang CC. Fuchs K. J. Med. Chem. 2003, 46: 5567

1e Parks DJ. LaFrance LV. Calvo RR. Milkiewicz KL. Gupta V. Lattanze J. Ramachandren K. Carver TE. Petrella EC. Cummings MD. Maguire D. Grasberger BL. Lu T. B. Bioorg. Med. Chem. Lett. 2005, 15: 765

For solid-phase synthesis of 1,4-benzodiazepine-2,5-diones, see:

2a Boojamra CG. Burow KM. Thompson LA. Ellman JA. J. Org. Chem. 1997, 62: 1240

2b Mayer JP. Zhang J. Bjergarde K. Lenz DM. Gaudino JJ. Tetrahedron Lett. 1996, 37: 8081

2c Hulme C. Peng J. Morton G. Salvino JM. Herpin T. Labaudiniere R. Tetrahedron Lett. 1998, 39: 7227

2d Kennedy AL. Fryer AM. Josey JA. Org. Lett. 2002, 4: 1167

For recent reviews, see:

3a Hermkens PHH. Ottenheijm HCJ. Rees D. Tetrahedron 1996, 52: 4527

3b Booth S. Hermkens PHH. Ottenheijm HCJ. Rees DC. Tetrahedron 1998, 54: 15385

3c Lorsbach BA. Kurth MJ. Chem. Rev. 1999, 99: 1549

3d Guillier F. Orain D. Bradley M. Chem. Rev. 2000, 100: 2091

3e Sammelson R. Kurth MJ. Chem. Rev. 2001, 101: 137

3f Krchòák V. Holladay W. Chem. Rev. 2002, 102: 61

3g Blaney P. Grigg R. Sridharan V. Chem. Rev. 2002, 102: 2607

4a Gravert DJ. Janda KD. Chem. Rev. 1997, 97: 489

4b Wentworth PJ. Janda KD. Chem. Commun. 1999, 1917

5a Toy PH. Janda KM. Acc. Chem. Res. 2000, 33: 546

5b Fishman A. Farrah ME. Zhong JH. Paramanantham S. Carrera C. Lee-Ruff E. J. Org.Chem. 2003, 68: 9843

5c Sauvagnat B. Kulig K. Lamaty F. Lazaro R. Martinez J. J. Comb. Chem. 2000, 2: 134

5d Chen S. Janda KD. J. Am. Chem. Soc. 1997, 119: 8724

5e Lin XF. Zhang J. Wang YG. Tetrahedron Lett. 2003, 44: 4113

5f Wang YG. Lin XF. Cui SL. Synlett 2004, 1175

6 For a recent review, see: Davis JHJ. Chem. Lett. 2004, 33: 1072

7a Fraga-Dubreuil J. Bazureau JP. Tetrahedron Lett. 2001, 42: 6097

7b Miao W. Chan TH. Org. Lett. 2003, 5: 5003

7c Fraga-Dubreuil J. Famelart MH. Bazureau JP. Org. Process Res. Dev. 2002, 6: 374

7d Fraga-Dubreuil J. Bazureau JP. Tetrahedron 2003, 59: 6121

8a Peng HD. Huang YL. Yang JH. Chen ZX. Yang GC. Comb. Chem. High Throughput Screening 2007, 10: 257

8b Zhang HQ. Yang GC. Chen JN. Chen ZX. Synthesis 2004, 3055

8c Rao Z. Peng HD. Yang GC. Chen ZX. Comb. Chem. High Throughput Screening 2006, 9: 1743

8d Chen ZX. Yue GZ. Lu CF. Yang GC. Synlett 2004, 1231

8e Yue GZ. Wan YD. Song SJ. Yang GC. Chen ZX. Bioorg. Med. Chem. Lett. 2005, 15: 453